This November's BIGMEDX Strategy Brief examines the escalating regulatory pressures that will shape the MedTech industry in 2026. From FDA's new QMSR reforms to global AI governance, supply-chain risks, and emerging-market challenges, this issue breaks down what companies must prepare for as compliance becomes the core driver of global expansion.